SUMMARY The purpose of this study was to determine if autonomic nerve interventions exerted quantitatively dissimilar effects on recovery properties of endocardium compared with epicardium. Effective refractory periods (ERP) were measured by the extrastimulus technique in the endocardium and epicardium of the canine left ventricular anterior wall. The basic train and premature stimuli were administered to the endocardium and overlying epicardium via different poles on the same multipolar needle electrode, using cathodal stimuli. Sympathetic augmentation produced via bilateral carotid arterial occlusion or electrical stimulation of right, left, and both sympathetic nerves shortened ERP. Bilateral sympathetic denervation prolonged ERP. The changes in ERP of the endocardium were no different than were changes in the ERP of overlying epicardium. In separate studies, electrical stimulation of the cervical vagi prolonged ERP similarly in epicardium and endocardium. Pacing at slower rates or physostigmine administration potentiated the ERP prolongation in endocardium similar to epicardium. Augmented sympathetic tone produced by carotid occlusion also potentiated prolonga- tion of ERP by vagal stimulation. The percent change in endocardial sites was slightly but significantly less than in epicardial sites. ERP prolongation due to vagal stimulation was attenuated markedly after sympathectomy and abolished with both propranolol and atropine. We conclude that, in the normal anterior left ventricular myocardium of the dog, sympathetic augmentation shortens ERP in epicardial sites equivalent to that in the underlying endocardial sites, that vagal nerve stimulation prolongs ERP in epicardial sites equal to or slightly greater than in the underlying endocardial sites, and that vagal stimulation antagonizes background sympathetic activity. Circ Res 46: 100-110, 1980
12 May 2003 in Journal of Cardiovascular Electrophysiology
Background A role for the Purkinje system in the development of spontaneous ventricular tachycardia (VT) during acute ischemia has been suspected but not proved. We used a three-dimensional activation mapping system incorporating Purkinje signals to characterize the mechanism and site of origin of spontaneous VT occurring in the first 30 minutes after coronary artery occlusion in a dog model. Methods and Results The left anterior descending coronary artery was occluded in 48 dogs after instrumentation of the risk zone with 21 multipolar plunge needles, each recording 6 bipolar electrograms through the myocardial wall. VT of Purkinje origin was defined as a focal endocardial VT with a Purkinje potential identified before muscle potential on the electrode recording the earliest activity. Purkinje potentials were identified on an average of 10 of the 21 plunge needles. During atrial pacing at cycle lengths of 300 to 700 ms, a total of 25 VTs were observed from 18 of the 48 dogs (37.5%). Of the VTs, 15 (60.0%) were of focal Purkinje origin, 1 (4.0%) of focal endocardial origin, 2 (8.0%) of focal midmyocardial origin, and 2 (8.0%) of focal epicardial origin; 3 (12.0%) had a reentrant mechanism, whereas in 2 (8.0%), the mechanism could not be defined. The mean cycle length of all VTs was 265±17 ms (mean±SEM, n=25). Of the 25 VTs, 19 originated from an ischemic area as defined by significant decreases in voltages of muscle electrograms at the time of occurrence of the VT, 4 originated from an ischemic border zone, and the origin of 2 could not be determined. Conclusions In this model, VT with a focal mechanism is commonly seen in the early ischemic period. Sixty percent of the VTs were of focal Purkinje origin as characterized by three-dimensional activation mapping. The results of this study indicate that Purkinje tissue may play an important role in the development of early ischemic VT.
Sixteen acromegalic patients underwent echocardiography, phonocardiography, stress electrocardiography with Thallium perfusion scanning and gated radioisotope left ventricular angiocardiograms. Abnormalities consisting of increased echo left ventricular mass index, low velocity of circumferential fiber shortening or elevated pre-ejection period to left ventricular ejection time ratio were found in six patients with coexistent hypertension or coronary disease. Concentric left ventricular hypertrophy was also found in three patients with no known etiology other than acromegaly of greater than thirteen years' duration or with fasting growth hormone concentrations greater than 100 ng/ml. One of these three also had left ventricular dysfunction. Neither hypertrophy nor ventricular dysfunction was found in other acromegalics with shorter duration of disease or lower growth hormone concentrations or with normal growth hormone concentrations after therapy. A high prevalence of coronary artery and hypertensive heart disease is associated with acromegaly. A few patients with acromegaly have a specific, potentially reversible cardiomyopathy probably related to prolonged acromegaly or very high growth hormone concentrations.